img

Global Arthritis Drug Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Arthritis Drug Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includesPsoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
The global Arthritis Drug market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
In terms of sales (consumption) side, this report focuses on the sales of Arthritis Drug by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Arthritis Drug market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Arthritis Drug market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Novartis
Eli Lilly
Celltrion
F. Hoffmann-La Roche
Pfizer
Johnson & Johnson
GSK
By Type
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
By Application
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Arthritis Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Arthritis Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Arthritis Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Arthritis Drug Definition
1.2 Market by Type
1.2.1 Global Arthritis Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Synthetic DMARDs
1.2.3 Biological DMARDs
1.2.4 NSAIDs
1.2.5 Corticosteroids
1.2.6 Analgesics
1.3 Market Segment by Application
1.3.1 Global Arthritis Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Drug Stores
1.3.5 E-Commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Arthritis Drug Sales
2.1 Global Arthritis Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Arthritis Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Arthritis Drug Revenue by Region
2.3.1 Global Arthritis Drug Revenue by Region (2018-2023)
2.3.2 Global Arthritis Drug Revenue by Region (2024-2034)
2.4 Global Arthritis Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Arthritis Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Arthritis Drug Sales Quantity by Region
2.6.1 Global Arthritis Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Arthritis Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Arthritis Drug Sales Quantity by Manufacturers
3.1.1 Global Arthritis Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Arthritis Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Arthritis Drug Sales in 2024
3.2 Global Arthritis Drug Revenue by Manufacturers
3.2.1 Global Arthritis Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Arthritis Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Arthritis Drug Revenue in 2024
3.3 Global Arthritis Drug Sales Price by Manufacturers
3.4 Global Key Players of Arthritis Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Arthritis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Arthritis Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Arthritis Drug, Product Offered and Application
3.8 Global Key Manufacturers of Arthritis Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Arthritis Drug Sales Quantity by Type
4.1.1 Global Arthritis Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Arthritis Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Arthritis Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Arthritis Drug Revenue by Type
4.2.1 Global Arthritis Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Arthritis Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Arthritis Drug Revenue Market Share by Type (2018-2034)
4.3 Global Arthritis Drug Price by Type
4.3.1 Global Arthritis Drug Price by Type (2018-2023)
4.3.2 Global Arthritis Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Arthritis Drug Sales Quantity by Application
5.1.1 Global Arthritis Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Arthritis Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Arthritis Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Arthritis Drug Revenue by Application
5.2.1 Global Arthritis Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Arthritis Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Arthritis Drug Revenue Market Share by Application (2018-2034)
5.3 Global Arthritis Drug Price by Application
5.3.1 Global Arthritis Drug Price by Application (2018-2023)
5.3.2 Global Arthritis Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Arthritis Drug Sales by Company
6.1.1 North America Arthritis Drug Revenue by Company (2018-2023)
6.1.2 North America Arthritis Drug Sales Quantity by Company (2018-2023)
6.2 North America Arthritis Drug Market Size by Type
6.2.1 North America Arthritis Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Arthritis Drug Revenue by Type (2018-2034)
6.3 North America Arthritis Drug Market Size by Application
6.3.1 North America Arthritis Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Arthritis Drug Revenue by Application (2018-2034)
6.4 North America Arthritis Drug Market Size by Country
6.4.1 North America Arthritis Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Arthritis Drug Revenue by Country (2018-2034)
6.4.3 North America Arthritis Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Arthritis Drug Sales by Company
7.1.1 Europe Arthritis Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Arthritis Drug Revenue by Company (2018-2023)
7.2 Europe Arthritis Drug Market Size by Type
7.2.1 Europe Arthritis Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Arthritis Drug Revenue by Type (2018-2034)
7.3 Europe Arthritis Drug Market Size by Application
7.3.1 Europe Arthritis Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Arthritis Drug Revenue by Application (2018-2034)
7.4 Europe Arthritis Drug Market Size by Country
7.4.1 Europe Arthritis Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Arthritis Drug Revenue by Country (2018-2034)
7.4.3 Europe Arthritis Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Arthritis Drug Sales by Company
8.1.1 China Arthritis Drug Sales Quantity by Company (2018-2023)
8.1.2 China Arthritis Drug Revenue by Company (2018-2023)
8.2 China Arthritis Drug Market Size by Type
8.2.1 China Arthritis Drug Sales Quantity by Type (2018-2034)
8.2.2 China Arthritis Drug Revenue by Type (2018-2034)
8.3 China Arthritis Drug Market Size by Application
8.3.1 China Arthritis Drug Sales Quantity by Application (2018-2034)
8.3.2 China Arthritis Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Arthritis Drug Sales by Company
9.1.1 APAC Arthritis Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Arthritis Drug Revenue by Company (2018-2023)
9.2 APAC Arthritis Drug Market Size by Type
9.2.1 APAC Arthritis Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Arthritis Drug Revenue by Type (2018-2034)
9.3 APAC Arthritis Drug Market Size by Application
9.3.1 APAC Arthritis Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Arthritis Drug Revenue by Application (2018-2034)
9.4 APAC Arthritis Drug Market Size by Region
9.4.1 APAC Arthritis Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Arthritis Drug Revenue by Region (2018-2034)
9.4.3 APAC Arthritis Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Arthritis Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Arthritis Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Arthritis Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Arthritis Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Arthritis Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Arthritis Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Arthritis Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Arthritis Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Arthritis Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Arthritis Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Arthritis Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Arthritis Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Arthritis Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Arthritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Novartis Arthritis Drug Products and Services
11.1.5 Novartis Arthritis Drug SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Overview
11.2.3 Eli Lilly Arthritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Eli Lilly Arthritis Drug Products and Services
11.2.5 Eli Lilly Arthritis Drug SWOT Analysis
11.2.6 Eli Lilly Recent Developments
11.3 Celltrion
11.3.1 Celltrion Company Information
11.3.2 Celltrion Overview
11.3.3 Celltrion Arthritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Celltrion Arthritis Drug Products and Services
11.3.5 Celltrion Arthritis Drug SWOT Analysis
11.3.6 Celltrion Recent Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Information
11.4.2 F. Hoffmann-La Roche Overview
11.4.3 F. Hoffmann-La Roche Arthritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 F. Hoffmann-La Roche Arthritis Drug Products and Services
11.4.5 F. Hoffmann-La Roche Arthritis Drug SWOT Analysis
11.4.6 F. Hoffmann-La Roche Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Arthritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Pfizer Arthritis Drug Products and Services
11.5.5 Pfizer Arthritis Drug SWOT Analysis
11.5.6 Pfizer Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Arthritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Johnson & Johnson Arthritis Drug Products and Services
11.6.5 Johnson & Johnson Arthritis Drug SWOT Analysis
11.6.6 Johnson & Johnson Recent Developments
11.7 GSK
11.7.1 GSK Company Information
11.7.2 GSK Overview
11.7.3 GSK Arthritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 GSK Arthritis Drug Products and Services
11.7.5 GSK Arthritis Drug SWOT Analysis
11.7.6 GSK Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Arthritis Drug Value Chain Analysis
12.2 Arthritis Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Arthritis Drug Production Mode & Process
12.4 Arthritis Drug Sales and Marketing
12.4.1 Arthritis Drug Sales Channels
12.4.2 Arthritis Drug Distributors
12.5 Arthritis Drug Customers
13 Market Dynamics
13.1 Arthritis Drug Industry Trends
13.2 Arthritis Drug Market Drivers
13.3 Arthritis Drug Market Challenges
13.4 Arthritis Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Arthritis Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Synthetic DMARDs
Table 3. Major Manufacturers of Biological DMARDs
Table 4. Major Manufacturers of NSAIDs
Table 5. Major Manufacturers of Corticosteroids
Table 6. Major Manufacturers of Analgesics
Table 7. Global Arthritis Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Arthritis Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Arthritis Drug Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Arthritis Drug Revenue Market Share by Region (2018-2023)
Table 11. Global Arthritis Drug Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Arthritis Drug Revenue Market Share by Region (2024-2034)
Table 13. Global Arthritis Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 14. Global Arthritis Drug Sales by Region (2018-2023) & (K Units)
Table 15. Global Arthritis Drug Sales Market Share by Region (2018-2023)
Table 16. Global Arthritis Drug Sales by Region (2024-2034) & (K Units)
Table 17. Global Arthritis Drug Sales Market Share by Region (2024-2034)
Table 18. Global Arthritis Drug Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 19. Global Arthritis Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Arthritis Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Arthritis Drug Revenue Share by Manufacturers (2018-2023)
Table 22. Global Arthritis Drug Price by Manufacturers 2018-2023 (USD/Unit)
Table 23. Global Key Players of Arthritis Drug, Industry Ranking, 2021 VS 2024
Table 24. Global Arthritis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Arthritis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arthritis Drug as of 2024)
Table 26. Global Key Manufacturers of Arthritis Drug, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Arthritis Drug, Product Offered and Application
Table 28. Global Key Manufacturers of Arthritis Drug, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Arthritis Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 31. Global Arthritis Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 32. Global Arthritis Drug Sales Quantity Share by Type (2018-2023)
Table 33. Global Arthritis Drug Sales Quantity Share by Type (2024-2034)
Table 34. Global Arthritis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Arthritis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Arthritis Drug Revenue Share by Type (2018-2023)
Table 37. Global Arthritis Drug Revenue Share by Type (2024-2034)
Table 38. Arthritis Drug Price by Type (2018-2023) & (USD/Unit)
Table 39. Global Arthritis Drug Price Forecast by Type (2024-2034) & (USD/Unit)
Table 40. Global Arthritis Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 41. Global Arthritis Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 42. Global Arthritis Drug Sales Quantity Share by Application (2018-2023)
Table 43. Global Arthritis Drug Sales Quantity Share by Application (2024-2034)
Table 44. Global Arthritis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Arthritis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Arthritis Drug Revenue Share by Application (2018-2023)
Table 47. Global Arthritis Drug Revenue Share by Application (2024-2034)
Table 48. Arthritis Drug Price by Application (2018-2023) & (USD/Unit)
Table 49. Global Arthritis Drug Price Forecast by Application (2024-2034) & (USD/Unit)
Table 50. North America Arthritis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Arthritis Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 52. North America Arthritis Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 53. North America Arthritis Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 54. North America Arthritis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Arthritis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Arthritis Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 57. North America Arthritis Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 58. North America Arthritis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Arthritis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Arthritis Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Arthritis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Arthritis Drug Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Arthritis Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 64. North America Arthritis Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 65. Europe Arthritis Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 66. Europe Arthritis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Arthritis Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 68. Europe Arthritis Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 69. Europe Arthritis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Arthritis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Arthritis Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 72. Europe Arthritis Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 73. Europe Arthritis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Arthritis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Arthritis Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Arthritis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Arthritis Drug Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Arthritis Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 79. Europe Arthritis Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 80. China Arthritis Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 81. China Arthritis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Arthritis Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 83. China Arthritis Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 84. China Arthritis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Arthritis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Arthritis Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 87. China Arthritis Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 88. China Arthritis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Arthritis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Arthritis Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 91. APAC Arthritis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Arthritis Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 93. APAC Arthritis Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 94. APAC Arthritis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Arthritis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Arthritis Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 97. APAC Arthritis Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 98. APAC Arthritis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Arthritis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Arthritis Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Arthritis Drug Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Arthritis Drug Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Arthritis Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 104. APAC Arthritis Drug Sales Quantity by Region (2024-2034) & (K Units)
Table 105. Middle East, Africa and Latin America Arthritis Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Arthritis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Arthritis Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East, Africa and Latin America Arthritis Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 109. Middle East, Africa and Latin America Arthritis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Arthritis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Arthritis Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 112. Middle East, Africa and Latin America Arthritis Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 113. Middle East, Africa and Latin America Arthritis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Arthritis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Arthritis Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Arthritis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Arthritis Drug Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Arthritis Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 119. Middle East, Africa and Latin America Arthritis Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 120. Novartis Company Information
Table 121. Novartis Description and Overview
Table 122. Novartis Arthritis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 123. Novartis Arthritis Drug Product and Services
Table 124. Novartis Arthritis Drug SWOT Analysis
Table 125. Novartis Recent Developments
Table 126. Eli Lilly Company Information
Table 127. Eli Lilly Description and Overview
Table 128. Eli Lilly Arthritis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 129. Eli Lilly Arthritis Drug Product and Services
Table 130. Eli Lilly Arthritis Drug SWOT Analysis
Table 131. Eli Lilly Recent Developments
Table 132. Celltrion Company Information
Table 133. Celltrion Description and Overview
Table 134. Celltrion Arthritis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 135. Celltrion Arthritis Drug Product and Services
Table 136. Celltrion Arthritis Drug SWOT Analysis
Table 137. Celltrion Recent Developments
Table 138. F. Hoffmann-La Roche Company Information
Table 139. F. Hoffmann-La Roche Description and Overview
Table 140. F. Hoffmann-La Roche Arthritis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 141. F. Hoffmann-La Roche Arthritis Drug Product and Services
Table 142. F. Hoffmann-La Roche Arthritis Drug SWOT Analysis
Table 143. F. Hoffmann-La Roche Recent Developments
Table 144. Pfizer Company Information
Table 145. Pfizer Description and Overview
Table 146. Pfizer Arthritis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 147. Pfizer Arthritis Drug Product and Services
Table 148. Pfizer Arthritis Drug SWOT Analysis
Table 149. Pfizer Recent Developments
Table 150. Johnson & Johnson Company Information
Table 151. Johnson & Johnson Description and Overview
Table 152. Johnson & Johnson Arthritis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 153. Johnson & Johnson Arthritis Drug Product and Services
Table 154. Johnson & Johnson Arthritis Drug SWOT Analysis
Table 155. Johnson & Johnson Recent Developments
Table 156. GSK Company Information
Table 157. GSK Description and Overview
Table 158. GSK Arthritis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 159. GSK Arthritis Drug Product and Services
Table 160. GSK Arthritis Drug SWOT Analysis
Table 161. GSK Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Arthritis Drug Distributors List
Table 165. Arthritis Drug Customers List
Table 166. Arthritis Drug Market Trends
Table 167. Arthritis Drug Market Drivers
Table 168. Arthritis Drug Market Challenges
Table 169. Arthritis Drug Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Arthritis Drug Product Picture
Figure 2. Global Arthritis Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Arthritis Drug Market Share by Type in 2024 & 2034
Figure 4. Synthetic DMARDs Product Picture
Figure 5. Biological DMARDs Product Picture
Figure 6. NSAIDs Product Picture
Figure 7. Corticosteroids Product Picture
Figure 8. Analgesics Product Picture
Figure 9. Global Arthritis Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Arthritis Drug Market Share by Application in 2024 & 2034
Figure 11. Retail Pharmacies
Figure 12. Hospital Pharmacies
Figure 13. Drug Stores
Figure 14. E-Commerce
Figure 15. Arthritis Drug Report Years Considered
Figure 16. Global Arthritis Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Arthritis Drug Revenue 2018-2034 (US$ Million)
Figure 18. Global Arthritis Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 19. Global Arthritis Drug Sales Quantity 2018-2034 (K Units)
Figure 20. Global Arthritis Drug Sales Quantity Market Share by Region (2018-2023)
Figure 21. Global Arthritis Drug Sales Quantity Market Share by Region (2024-2034)
Figure 22. North America Arthritis Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. North America Arthritis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Arthritis Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. Europe Arthritis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Arthritis Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. China Arthritis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 28. APAC Arthritis Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 29. APAC Arthritis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Arthritis Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 31. Middle East, Africa and Latin America Arthritis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Arthritis Drug Sales Quantity in 2024
Figure 33. The Top 10 and Top 5 Players Market Share by Arthritis Drug Revenue in 2024
Figure 34. Arthritis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 35. Global Arthritis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 36. Global Arthritis Drug Revenue Market Share by Type (2018-2034)
Figure 37. Global Arthritis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 38. Global Arthritis Drug Revenue Market Share by Application (2018-2034)
Figure 39. North America Arthritis Drug Revenue Market Share by Company in 2024
Figure 40. North America Arthritis Drug Sales Quantity Market Share by Company in 2024
Figure 41. North America Arthritis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 42. North America Arthritis Drug Revenue Market Share by Type (2018-2034)
Figure 43. North America Arthritis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 44. North America Arthritis Drug Revenue Market Share by Application (2018-2034)
Figure 45. North America Arthritis Drug Revenue Share by Country (2018-2034)
Figure 46. North America Arthritis Drug Sales Quantity Share by Country (2018-2034)
Figure 47. U.S. Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 48. Canada Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 49. Europe Arthritis Drug Sales Quantity Market Share by Company in 2024
Figure 50. Europe Arthritis Drug Revenue Market Share by Company in 2024
Figure 51. Europe Arthritis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 52. Europe Arthritis Drug Revenue Market Share by Type (2018-2034)
Figure 53. Europe Arthritis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 54. Europe Arthritis Drug Revenue Market Share by Application (2018-2034)
Figure 55. Europe Arthritis Drug Revenue Share by Country (2018-2034)
Figure 56. Europe Arthritis Drug Sales Quantity Share by Country (2018-2034)
Figure 57. Germany Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 58. France Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 59. U.K. Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 60. Italy Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 61. Russia Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 62. China Arthritis Drug Sales Quantity Market Share by Company in 2024
Figure 63. China Arthritis Drug Revenue Market Share by Company in 2024
Figure 64. China Arthritis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 65. China Arthritis Drug Revenue Market Share by Type (2018-2034)
Figure 66. China Arthritis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 67. China Arthritis Drug Revenue Market Share by Application (2018-2034)
Figure 68. APAC Arthritis Drug Sales Quantity Market Share by Company in 2024
Figure 69. APAC Arthritis Drug Revenue Market Share by Company in 2024
Figure 70. APAC Arthritis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 71. APAC Arthritis Drug Revenue Market Share by Type (2018-2034)
Figure 72. APAC Arthritis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 73. APAC Arthritis Drug Revenue Market Share by Application (2018-2034)
Figure 74. APAC Arthritis Drug Revenue Share by Region (2018-2034)
Figure 75. APAC Arthritis Drug Sales Quantity Share by Region (2018-2034)
Figure 76. Japan Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 77. South Korea Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 78. China Taiwan Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 79. Southeast Asia Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 80. India Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 81. Middle East, Africa and Latin America Arthritis Drug Sales Quantity Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Arthritis Drug Revenue Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America Arthritis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Arthritis Drug Revenue Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Arthritis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Arthritis Drug Revenue Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Arthritis Drug Sales Quantity Share by Country (2018-2034)
Figure 88. Middle East, Africa and Latin America Arthritis Drug Revenue Share by Country (2018-2034)
Figure 89. Brazil Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 90. Mexico Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Turkey Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 92. Israel Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 93. GCC Countries Arthritis Drug Revenue (2018-2034) & (US$ Million)
Figure 94. Arthritis Drug Value Chain
Figure 95. Arthritis Drug Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries